Schwahofer A, Jäkel O
Abteilung Medizinische Physik in der Strahlentherapie, Deutsches Krebsforschungszentrum Heidelberg, Im Neuenheimer Feld 280, 69120, Heidelberg, Deutschland.
Radiologe. 2018 Aug;58(8):736-745. doi: 10.1007/s00117-018-0419-z.
CLINICAL/METHODICAL ISSUE: As a standard, today's radiation therapy is based on CT images which are used for therapy planning. These images are obtained once before therapy starts and serve as a basis to obtain the position and shape of the target volume. As the patient has to be positioned anew for each fraction, deviations of the tumor position relative to the radiation field but also internal motion of the tumor may occur. These deviations lead to uncertainties, which are taken into account by adding a safety margin around the clinical target volume (CTV) to create the planning target volume (PTV).
As a standard today, CT-based treatment planning is used, where images are obtained once prior to therapy. The information on tumor position and shape, which is obtained from these images, is used throughout the whole cycle of radiation therapy without any change. This cycle may last several weeks.
By repeated imaging of the patient in the treatment position prior to each fraction, the position of the tumor can be assessed and corrected for each fraction.
A reduction of positioning uncertainty may be used to reduce the safety margin. This leads to a decreased volume of irradiated normal tissue.
A reduced volume of irradiated normal tissue leads to reduced side effects and provides the opportunity of increased tumor control by dose escalation.
Before the PTV is reduced, a detailed analysis of the uncertainties for the specific imaging method and radiation technique must be performed.
临床/方法学问题:作为标准做法,如今的放射治疗基于用于治疗计划的CT图像。这些图像在治疗开始前获取一次,用作确定靶区体积的位置和形状的基础。由于每次分割治疗时患者都必须重新定位,肿瘤位置相对于辐射野可能会出现偏差,而且肿瘤内部也可能发生移动。这些偏差会导致不确定性,为此会在临床靶区(CTV)周围增加一个安全边界来创建计划靶区(PTV),从而将这些不确定性考虑在内。
如今的标准做法是采用基于CT的治疗计划,在治疗前获取一次图像。从这些图像中获得的肿瘤位置和形状信息在整个放射治疗周期中使用,不会有任何变化。这个周期可能持续数周。
通过在每次分割治疗前对处于治疗体位的患者进行重复成像,可以评估并校正每次分割治疗时肿瘤的位置。
定位不确定性的降低可用于减小安全边界。这会使受照射正常组织的体积减小。
受照射正常组织的体积减小会导致副作用减少,并通过提高剂量提供增强肿瘤控制的机会。
在减小PTV之前,必须对特定成像方法和放射技术的不确定性进行详细分析。